B
Bull
Bull · 25%SINT
$2.63
Scenario price
$1.500
-0.029 (-1.96%)At close
Loading chart…
- High
- 1.531
- Open
- 1.510
- VWAP
- 1.50
- Vol
- 18.63K
- Mkt Cap
- 3.17M
- Low
- 1.480
- Amount
- 28.02K
- EV/EBITDA, TTM
- -0.29
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
AI analysis of SINTX Technologies Inc (SINT)
holdSINTX Technologies Inc is currently not a good buy due to its low price of $1.50, which is significantly below its analyst price targets of $6 and $10. However, the stock has a low RSI of 35.04, indicating it may be oversold. The main risk is its substantial year-to-date decline of 60.32%, suggesting ongoing challenges.
Valuation Metrics
The current forward P/E ratio for SINTX Technologies Inc (SINT) is 0.00, compared to its 5-year average forward P/E of -18.66.
Alphio AI Price Scenarios for SINT
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
8.508-13NewsfilterSINTX Technologies Regains Nasdaq Compliance with Equity Requirements
- 8.508-11Newsfilter
SINTX Technologies Provides Business Update for Q2 2026
- 9.507-28Newsfilter
SINTX Technologies to Release Q2 2026 Financial Results
- 4.507-23Newsfilter
SINTX Technologies Launches Strategic Opportunity Management Program
- 7.506-22Newsfilter
SINTX Secures Over $3.2 Million in Orders
SINT FAQ — answered by Alphio AI
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
SINTX Technologies Inc is currently not a good buy due to its low price of $1.50, which is significantly below its analyst price targets of $6 and $10. However, the stock has a low RSI of 35.04, indicating it may be oversold. The main risk is its substantial year-to-date decline of 60.32%, suggesting ongoing challenges.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.